458 related articles for article (PubMed ID: 17587493)
1. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice.
Kleiman A; Tuckermann JP
Mol Cell Endocrinol; 2007 Sep; 275(1-2):98-108. PubMed ID: 17587493
[TBL] [Abstract][Full Text] [Related]
2. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
Schäcke H; Berger M; Rehwinkel H; Asadullah K
Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
[TBL] [Abstract][Full Text] [Related]
3. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
Huisman AM; Jacobs JW; Buttgereit F; Bijlsma JW
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):476-80. PubMed ID: 16553045
[TBL] [Abstract][Full Text] [Related]
4. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
McMaster A; Ray DW
Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of steroid receptor function by gene targeting in mice.
Wintermantel TM; Berger S; Greiner EF; Schütz G
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):107-12. PubMed ID: 15860252
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects.
Kassel O; Herrlich P
Mol Cell Endocrinol; 2007 Sep; 275(1-2):13-29. PubMed ID: 17689856
[TBL] [Abstract][Full Text] [Related]
7. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Newton R; Holden NS
Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
[TBL] [Abstract][Full Text] [Related]
8. Selective glucocorticoid receptor agonists for the treatment of inflammatory bowel disease: studies in mice with acute trinitrobenzene sulfonic acid colitis.
Reuter KC; Grunwitz CR; Kaminski BM; Steinhilber D; Radeke HH; Stein J
J Pharmacol Exp Ther; 2012 Apr; 341(1):68-80. PubMed ID: 22235147
[TBL] [Abstract][Full Text] [Related]
9. Ontogeny of hippocampal corticosteroid receptors: effects of antenatal glucocorticoids in human and mouse.
Noorlander CW; De Graan PN; Middeldorp J; Van Beers JJ; Visser GH
J Comp Neurol; 2006 Dec; 499(6):924-32. PubMed ID: 17072842
[TBL] [Abstract][Full Text] [Related]
10. Genetic dissection of corticosteroid receptor function in mice.
Wintermantel TM; Berger S; Greiner EF; Schütz G
Horm Metab Res; 2004 Jun; 36(6):387-91. PubMed ID: 15241729
[TBL] [Abstract][Full Text] [Related]
11. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
12. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor.
Reichardt HM; Tuckermann JP; Göttlicher M; Vujic M; Weih F; Angel P; Herrlich P; Schütz G
EMBO J; 2001 Dec; 20(24):7168-73. PubMed ID: 11742993
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.
Löwenberg M; Stahn C; Hommes DW; Buttgereit F
Steroids; 2008 Oct; 73(9-10):1025-9. PubMed ID: 18221974
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of action of glucocorticoids in asthma].
Jaffuel D; Mathieu M; Godard P; Michel FB; Demoly P
Rev Mal Respir; 1999 Sep; 16(4):431-42. PubMed ID: 10549054
[TBL] [Abstract][Full Text] [Related]
15. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index.
Schäcke H; Rehwinkel H; Asadullah K; Cato AC
Exp Dermatol; 2006 Aug; 15(8):565-73. PubMed ID: 16842594
[TBL] [Abstract][Full Text] [Related]
16. The effect of CAG repeat length polymorphism in the murine glucocorticoid receptor on transactivation potential.
Yee KS; Cho K; Green T; Chandler J; Greenhalgh DG
Exp Mol Pathol; 2008 Jun; 84(3):200-5. PubMed ID: 18538320
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions.
Marchetti B; Serra PA; Tirolo C; L'episcopo F; Caniglia S; Gennuso F; Testa N; Miele E; Desole S; Barden N; Morale MC
Brain Res Brain Res Rev; 2005 Apr; 48(2):302-21. PubMed ID: 15850669
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic analysis of glucocorticoid signaling using the Cre/loxP system.
Reichardt HM; Tronche F; Bauer A; Schütz G
Biol Chem; 2000; 381(9-10):961-4. PubMed ID: 11076028
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.
Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP
Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
Chinenov Y; Rogatsky I
Mol Cell Endocrinol; 2007 Sep; 275(1-2):30-42. PubMed ID: 17576036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]